Skip to content

Released Aug 12, 2022, before the open

10-Q filed Aug 12, 2022, 43 days after period end · 0001789769-22-000069

Q2 2022 · 10-Q
Revenue—
Net Income-$58.99MN/M vs Q2 2021N/M vs Q1 2022
EPS Diluted-$0.46N/M vs Q2 2021N/M vs Q1 2022
Operating Income-$58,724,000N/M
Operating Cash Flowderived-$47,260,000N/M
Free Cash Flowderived-$73,403,000N/M

What the release said

The release

Same quarter

MetricQ2 2022Q2 2021Q2 2020
Revenue—$0.00$42.00K
Net Income-$58.99M-$35.31M-$9.20M
EPS Diluted-$0.46-$0.27-$0.55

The same fiscal quarter, prior years. Thaler holds no estimates to compare against.

Instil Bio, Inc. · CIK 1789769 · Engraved from SEC EDGAR